Chronic Renal Failure After Liver Transplantation
Innate Immunity and Organ Transplantation
Paul E. Lacy, MD, PhD February 7, 1924 to February 15, 2005
CTLA4 Engagement is Required for Induction of Murine Liver Transplant Spontaneous Tolerance†
Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2
Lung Preservation
Inosculation of Tissue-Engineered Capillaries with the Host's Vasculature in a Reconstructed Skin Transplanted on Mice
Warfarin or Low-Molecular-Weight Heparin Therapy does not Prolong Pig-To-Primate Cardiac Xenograft Function
Anti-CD154 mAb Treatment But Not Recipient CD154 Deficiency Leads to Long-Term Survival of Xenogeneic Islet Grafts
IDEC-131 (Anti-CD154), Sirolimus and Donor-Specific Transfusion Facilitate Operational Tolerance in Non-Human Primates
Activation of Pro-Inflammatory and Anti-Inflammatory Cytokines in Host Organs During Chronic Allograft Rejection
Incidence of C4d Stain in Protocol Biopsies from Renal Allografts
Obesity in Living Kidney Donors
Clinical Utility of Cytomegalovirus (CMV) Serology Testing in High-risk CMV D+/R− Transplant Recipients
A Comparison of Long-Term Graft Survival Rates Between the First and Second Donor Kidney Transplanted—The Effect of a Longer Cold Ischaemic Time for the Second Kidney
Significance of CT Attenuation Value in Liver Grafts Following Right Lobe Living-Donor Liver Transplantation
Rapamycin Successfully Treats Post-Transplant Autoimmune Hepatitis
Consequences of Eliminating HLA-B in Deceased Donor Kidney Allocation to Increase Minority Transplantation
Functional Status and Quality of Life in Patients Surviving 10 years After Lung Transplantation
Hospital-Independent Organ Recovery from Deceased Donors
A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation
Renal Histopathological Lesions After Orthotopic Liver Transplantation (OLT)
Kidney Allograft Fibrosis and Atrophy Early After Living Donor Transplantation
Recrudescent Tobacco Exposure Following Heart Transplantation
To Do or Not to Do Living Donor Hepatectomy in Jehovah's Witnesses
Hemolytic Uremic Syndrome
Successful Outcome of Progressive Multifocal Leukoencephalopathy in a Renal Transplant Patient
Heart Transplantation in a 68-Year-Old Patient with Senile Systemic Amyloidosis
Update on Guidelines for Prevention and Management of Mycobacterium Tuberculosis Infections After Transplant
Mycophenolate Sodium Does Not Reduce the Incidence of GI Adverse Events Compared with Mycophenolate Mofetil
Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF), it is Better to Have the Choice
A Congressional Gold Medal for Transplant Donors and Families
Preservation of Renal Structure and Function at 2 Years without Calcineurin Inhibitor Use
Response to
Conscription of Cadaveric Organs
How Should We Ethically Select Living Kidney Donors When They All Are at Risk?